RussellShepherdLewisJrMD

PubMed

• 4 citations
  Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options
  Russell Lewis, Jan Philipp Bewersdorf, Amer M. Zeidan> ;Cancer Management and Research. 2021 Jan 25
• 1 citations
  Fedratinib hydrochloride to treat intermediate-2 or high-risk primary or secondary myelofibrosis.
  Molly Schiffer, Andrew Kowalski, Jennifer Zhao, Jan Philipp Bewersdorf, Russell Lewis, Amer M. Zeidan> ;Drugs of Today. 2020 Dec 1
• 2 citations
  Hypomethylating agent based combinations in higher risk myelodysplastic syndrome
  Namrata S. Chandhok, Russell Lewis, Thomas Prebet> ;Leukemia & Lymphoma. 2020 Apr 15
• 55 citations
  The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)
  Matthew T. McMillan, Russell S. Lewis, Jeffrey A. Drebin, Ursina R. Teitelbaum, Major K. Lee, Robert E. Roses, Douglas L. Fraker, Charles M. Vollmer> ;Cancer. 2016 Feb 15
• 14 citations
  Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival
  Lea Lowenfeld, Jashodeep Datta, Russell S. Lewis, Matthew T. McMillan, Ronac Mamtani, Nevena Damjanov, Vinay Chandrasekhara, Giorgos C. Karakousis, Jeffrey A. Drebin, ...> ;Annals of Surgical Oncology. 2015 Jun 23
• 20 citations
  Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model.
  Jashodeep Datta, Matthew T. McMillan, Eric K. Shang, Ronac Mamtani, Russell S. Lewis, Rachel R. Kelz, Ursina R. Teitelbaum, John P. Plastaras, Jeffrey A. Drebin, Dougl...> ;Journal of the National Comprehensive Cancer Network. 2015 May 1
• 71 citations
  Establishing a quantitative benchmark for morbidity in pancreatoduodenectomy using ACS-NSQIP, the Accordion Severity Grading System, and the Postoperative Morbidity In...
  Charles M. Vollmer, Russell S. Lewis, Bruce L. Hall, John D. Allendorf, Joal D. Beane, Stephen W. Behrman, Mark P. Callery, John D. Christein, Jeffrey A. Drebin, Irene...> ;Annals of Surgery. 2015 Mar 1
• 20 citations
  Quantifying the Burden of Complications Following Total Pancreatectomy Using the Postoperative Morbidity Index: A Multi-Institutional Perspective
  Jashodeep Datta, Russell S. Lewis, Steven M. Strasberg, Bruce L. Hall, John D. Allendorf, Joal D. Beane, Stephen W. Behrman, Mark P. Callery, John D. Christein, Jeffre...> ;Journal of Gastrointestinal Surgery. 2015 Mar 1
• 69 citations
  Prophylactic octreotide for pancreatoduodenectomy: more harm than good?
  Matthew T. McMillan, John D. Christein, Mark P. Callery, Stephen W. Behrman, Jeffrey A. Drebin, Tara S. Kent, Benjamin C. Miller, Russell S. Lewis, Charles M. Vollmer> ;HPB. 2014 Oct 1
• 30 citations
  Defining the post-operative morbidity index for distal pancreatectomy
  Major K. Lee, Russell S. Lewis, Steven M. Strasberg, Bruce L. Hall, John D. Allendorf, Joal D. Beane, Stephen W. Behrman, Mark P. Callery, John D. Christein, Jeffrey A...> ;HPB. 2014 Oct 1
• 56 citations
  Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base.
  Jashodeep Datta, Russell S. Lewis, Ronac Mamtani, Diana Stripp, Rachel R. Kelz, Jeffrey A. Drebin, Douglas L. Fraker, Giorgos C. Karakousis, Robert E. Roses> ;Cancer. 2014 Sep 15
• 32 citations
  Assessing the impact of a fistula after a pancreaticoduodenectomy using the Post-operative Morbidity Index
  Benjamin C. Miller, John D. Christein, Stephen W. Behrman, Mark P. Callery, Jeffrey A. Drebin, Tara S. Kent, Russell S. Lewis, Charles M. Vollmer> ;HPB. 2013 Oct 1
• 82 citations
  A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma
  Russell S. Lewis, Jeffrey A. Drebin, Mark P. Callery, Douglas L. Fraker, Tara S. Kent, Jenna Gates, Charles M. Vollmer> ;HPB. 2013 Jan 1
• 10 citations
  Risk Scores and Prognostic Models in Surgery: Pancreas Resection as a Paradigm
  Russell S. Lewis, Charles M. Vollmer> ;Current Problems in Surgery. 2012 Dec 1
• Join now to see all